Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression, Immunogenicity, Histopathology, and Potency of a Mosquito-Based Malaria Transmission-Blocking Recombinant Vaccine

7 Feb 2012

Abstract excerpt

Vaccines have been at the forefront of global research efforts to combat malaria, yet despite several vaccine candidates, this goal has yet to be realized. A potentially effective approach to disrupting the spread of malaria is the use of transmission-blocking vaccines (TBV), which prevent the development of malarial parasites within their mosquito vector, thereby abrogating the cascade of secondary infections in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Malaria Research and Control
Share to Mosquito-borne diseases and control
Share to Trypanosoma species research and implications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22311924
DOI: 10.1128/iai.06212-11

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression, Immunogenicity, Histopathology, and Potency of a Mosquito-Based Malaria Transmission-Blocking Recombinant VaccinePMID 22311924Read ↗

Toward the development of effective transmission-blocking vaccines for malariaSemantic proximity Read ↗

The Anopheles-midgut APN1 structure reveals a new malaria transmission–blocking vaccine epitopeSemantic proximity Read ↗

<i>Plasmodium</i> P25 and P28 Surface Proteins: Potential Transmission-Blocking VaccinesSemantic proximity Read ↗

Monoclonal Antibody MG96 Completely Blocks <i>Plasmodium yoelii</i> Developmentin <i>Anophelesstephensi</i>Semantic proximity Read ↗

Heterologous Expression and Evaluation of Novel Plasmodium falciparum Transmission Blocking Vaccine CandidatesSemantic proximity Read ↗

Advances and challenges in malaria vaccine developmentSemantic proximity Read ↗

In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response.Semantic proximity Read ↗

Recombinant Viral-Vectored Vaccines Expressing Plasmodium chabaudi AS Apical Membrane Antigen 1: Mechanisms of Vaccine-Induced Blood-Stage ProtectionSemantic proximity Read ↗

Transmission blocking vaccines to control insect-borne diseases: a reviewSemantic proximity Read ↗

Apical membrane antigen 1: a malaria vaccine candidate in reviewSemantic proximity Read ↗

The Plasmodium berghei sexual stage antigen PSOP12 induces anti-malarial transmission blocking immunity both in vivo and in vitroSemantic proximity Read ↗

Low immunogenicity of malaria pre-erythrocytic stages can be overcome by vaccinationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.